European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease -March 13, 2024 at 04:03 am EDT : vimarsana.com

PREVENAR 20® offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of...

Related Keywords

Espa , Hordaland , Norway , Spain , Liechtenstein , Brazil , Canada , Australia , Italy , United States , Iceland , Lichtenstein , , European Commission Decision , Pfizer , Youtube , Pfizer Inc , Drug Administration , Exchange Commission , European Union , Linkedin , European Commission , National Center , Alexandre De Germay , Chief International Commercial Officer , Executive Vice President , European Medicines Agency , Medicinal Products , Human Use , Pneumococcal Conjugate Vaccine , United States Food , Breakthroughs That Change Patient , Pfizer News , Annual Report , Looking Information , Factors That May Affect Future , Bacterial Core , Lancet Infect , Hum Vaccin , Pediatric Infectious Disease , Published September , Markets ,